Journal
TRANSLATIONAL PSYCHIATRY
Volume 11, Issue 1, Pages -Publisher
SPRINGERNATURE
DOI: 10.1038/s41398-021-01511-7
Keywords
-
Categories
Funding
- Intramural Research Program of the National Institutes of Health, National Institute on Drug Abuse
- National Institute on Alcohol Abuse and Alcoholism
- National Institutes of Health [DA 048530]
- Trigemina, Inc.
Ask authors/readers for more resources
The study found that intranasal oxytocin can reach the brain via the olfactory and trigeminal neural pathways, but the addition of a mucoadhesive did not enhance its concentration in the brain.
There is evidence of the therapeutic potential of intranasal oxytocin for the treatment of pain and various psychiatric disorders, however, there is scant evidence that oxytocin reaches the brain. We quantified the concentration and distribution pattern of [I-125]-radiolabeled oxytocin in the brains and peripheral tissues of rats after intranasal delivery using gamma counting and autoradiography, respectively. Radiolabel was detected in high concentrations in the trigeminal and olfactory nerves as well as in brain regions along their trajectories. Considerable concentrations were observed in the blood, however, relatively low levels of radiolabel were measured in peripheral tissues. The addition of a mucoadhesive did not enhance brain concentrations. These results provide support for intranasal OT reaching the brain via the olfactory and trigeminal neural pathways. These findings will inform the design and interpretation of clinical studies with intranasal oxytocin.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available